SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11934319
Source:
http://linkedlifedata.com/resource/pubmed/id/11934319
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0034897
,
umls-concept:C0035335
,
umls-concept:C0036563
,
umls-concept:C0524801
,
umls-concept:C0681890
,
umls-concept:C1521761
,
umls-concept:C2699708
pubmed:issue
4
pubmed:dateCreated
2002-4-5
pubmed:abstractText
To identify the clinical features of eyes with retinoblastomas that predict the recurrence of retinal tumors, vitreous seeds, and subretinal seeds following treatment with chemoreduction.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7706534
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide
,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0003-9950
pubmed:author
pubmed-author:DemirciHakanH
,
pubmed-author:HonavarSantosh GSG
,
pubmed-author:MeadowsAnna TAT
,
pubmed-author:NaduvilathThomas JohnTJ
,
pubmed-author:ShieldsCarol LCL
,
pubmed-author:ShieldsJerry AJA
pubmed:issnType
Print
pubmed:volume
120
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
460-4
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11934319-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:11934319-Carboplatin
,
pubmed-meshheading:11934319-Combined Modality Therapy
,
pubmed-meshheading:11934319-Etoposide
,
pubmed-meshheading:11934319-Eye Neoplasms
,
pubmed-meshheading:11934319-Humans
,
pubmed-meshheading:11934319-Infant
,
pubmed-meshheading:11934319-Neoplasm Recurrence, Local
,
pubmed-meshheading:11934319-Neoplasm Seeding
,
pubmed-meshheading:11934319-Prospective Studies
,
pubmed-meshheading:11934319-Retinal Neoplasms
,
pubmed-meshheading:11934319-Retinoblastoma
,
pubmed-meshheading:11934319-Risk Factors
,
pubmed-meshheading:11934319-Treatment Outcome
,
pubmed-meshheading:11934319-Vincristine
,
pubmed-meshheading:11934319-Vitreous Body
pubmed:year
2002
pubmed:articleTitle
Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
pubmed:affiliation
Ocular Oncology Service, Wills Eye Hospital, 900 Walnut St, Philadelphia, PA 19107, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, Non-U.S. Gov't